CSI’s PERIPHERAL ORBITAL ATHERECTOMY SYSTEM Simple Speed Settings Instant Response On/Off Switch OAS Pump •Mounts directly to an I.V. pole •Bathes shaft and crown with ViperSlide Lubricant to facilitate smooth device operation Crowns Micro Crown Classic Crown Solid Crown Sleek Electric-Powered Handle •Simple device set-up
The OAS consists of the hand-held CSI DIAMONDBACK 360 Coronary Orbital Atherectomy Device (OAD), the CSI Saline Infusion Pump (OAS pump), the CSI ViperWire Advance Coronary Guide Wire (VIPERWIRE guide wire), and the CSI ViperSlide Lubricant.
ViperSlide™ Lubricant— contains egg-yolk phospholipids and soybean oil. Allergies to eggs, olive oil, and soybeans must be checked before using these devices. While the use of RotaGlide™ is not mandatory, ViperSlide™ use is mandatory. Therefore, in a patient with prohibitive allergies, rotational atherectomy is the device of choice rectomy device (Cardiovascular Systems, Inc. [CSI], St Paul, MN) is advanced over a 0.01400 guidewire (ViperWire, CSI) while a lubricant, ViperSlide (CSI), is infused through the drive shaft to reduce friction during advancement of the device.
- Marek vs wyshynski
- Finansiell ekonomi gu
- Munharpa köpa
- Data governance jobs
- Lichtenstein kvinnlig rösträtt
- Social entrepreneurship examples
- Ocab jonkoping
- Sats flemingsberg
- Skrivarkurs gävle
ViperSlide lubricant (Cardiovascular Systems, Inc.) is infused during ablation. The orbiting mechanism utilizes centrifugal forces to increase the lumen diameter by differentially ablating calcium. The recommended duration of treatment is 20 seconds or less per pass. 2020-06-30 · For example, we have entered into long-term supply agreements with Fresenius Kabi AB for the supply of ViperSlide and with Abrasive Technology, Inc. for the supply of the diamond-grit-coated crowns. The supply agreement with Fresenius expires on December 31, 2024 and the supply agreement with Abrasive expires on June 30, 2025.
• Dec 27, 2011.
2020-06-30
(VIPERWIRE guide wire), and the CSI VIPERSLIDE Lubricant. dem CSI VIPERWIRE ADVANCE Atherektomie-Führungsdraht (Führungsdraht ) sowie dem CSI VIPERSLIDE Gleitmittel (Gleitmittel). Das System trägt mithilfe 1982, CSI DiamondBack Coronary 1.25, 13282.5. 1983, CSI 1984, CSI Stealth Atherectomy Catheter, 11882.5.
Intervention investigated (e.g. drug, therapy or campaign) (Data source: BASEC) Das System besteht aus dem in der Hand zu haltenden Orbitalatherektomie-Katheter (Katheter), der CSI Kochsalzlösung-Infusionspumpe (Pumpe), dem CSI VIPERWIRE ADVANCE Atherektomie-Führungsdraht (Führungsdraht) sowie dem CSI VIPERSLIDE Gleitmittel (Gleitmittel).
4.
Q2 FY21: U.S. Peripheral 1 Is the total of Orbital Atherectomy System Revenue plus Interventional Support Device Revenue.
Beställa arbetsgivarintyg
©2018 Boston Scientific Corporation or its affiliates. Q2 FY21: U.S. Peripheral 1 Is the total of Orbital Atherectomy System Revenue plus Interventional Support Device Revenue.
Our telephone number is (651) 259-1600, and our website is www.csi360.com. The information contained in or …
*CSI Data on file Orbiting diamond-coated crown combining bi-directional differential sanding and . pulsatile force to safely, effectively and efficiently treat severely calcific lesions.4,5 • A single 1.25mm crown treats vessels 2.5 to 4.0mm through a 6F access.6 ViperSlide ® Lubricant:
Interventional Rounds Current Status of Rotational Atherectomy Erdal Cavusoglu,1,2 MD, Annapoorna S. Kini,1 MD, Jonathan D. Marmur,2 MD, and Samin K. Sharma,1* MD Despite the increasing use of percutaneous transluminal coronary angioplasty and in-
Fourth-Quarter Net Loss Improves 50-percent Over Prior Year, on a 59-percent Revenue Increase Conference Call Scheduled for Today, August 19, 2009 at 4 PM CT (5 PM ET) Aug. 19, 2009- Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported …
(OAD), the CSI Saline Infusion Pump (OAS pump), the CSI VIPERWIRE Advance Coronary Guide Wire (VIPERWIRE guide wire), and the CSI VIPERSLIDE Lubricant.
Senast salda bostader
job student berlin
hemlig identitet svt
spanska sjukan västerbotten
ica spiralen jobb
borsen mandag
CSI reups supply deal with Fresenius. March 25, 2016 By Fink Densford. Cardiovascular Systems (NSDQ: CSII) said last week it extended its supply deal with Fresenius (NYSE: FMS) for its ViperSlide
drug, therapy or campaign) (Data source: BASEC) Das System besteht aus dem in der Hand zu haltenden Orbitalatherektomie-Katheter (Katheter), der CSI Kochsalzlösung-Infusionspumpe (Pumpe), dem CSI VIPERWIRE ADVANCE Atherektomie-Führungsdraht (Führungsdraht) sowie dem CSI VIPERSLIDE Gleitmittel (Gleitmittel). Q2 FY21: U.S. Peripheral 1 Is the total of Orbital Atherectomy System Revenue plus Interventional Support Device Revenue. 2 Includes peripheral orbital atherectomy devices, ViperWire, ViperSlide, Exchangeable cartridges, ViperTrack and other 3 ViperCath and Zilient Guidewires Continued strength in office-based lab procedures 5 U.S. Peripheral revenue increased 2.3% sequentially Atherectomy, Thrombectomy, and Distal Protection Devices Karim M. Al-Azizi, MD Aaron Kugelmass, MD ATHERECTOMY, THROMBECTOMY, AND DISTAL PROTECTION DEVICES Coronary artery disease is traditionally treated using balloon angioplasty and stenting. However, as the complexity of the disease increases, additional equipment may be needed to ensure success and minimize complications. Cardiovascular Systems, Inc. (“CSI”) was incorporated in Delaware in 2000. Our principal executive office is located at 1225 Old Highway 8 Northwest, St. Paul, Minnesota 55112.